The shortage of human tissues, caused by the inability to preserve them, severely constrains drug discovery. It adds cost. It adds time. And it adds error.  New molecules must be tested in animal models and then tested in humans, instead of using human tissue model and primary cells from the beginning. And no doubt there are molecules that fail in animal models but would be successful in humans.